PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $680,608 | -57.0% | 30,352 | -22.3% | 0.00% | -50.0% |
Q2 2023 | $1,582,148 | +131.9% | 39,067 | +182.6% | 0.00% | +100.0% |
Q1 2023 | $682,286 | -59.7% | 13,826 | -69.7% | 0.00% | -50.0% |
Q4 2022 | $1,690,954 | +110.6% | 45,566 | +189.2% | 0.00% | +100.0% |
Q3 2022 | $803,000 | -17.1% | 15,758 | -34.7% | 0.00% | 0.0% |
Q2 2022 | $969,000 | -58.1% | 24,147 | -61.0% | 0.00% | -66.7% |
Q1 2022 | $2,313,000 | -18.8% | 61,889 | -12.5% | 0.00% | 0.0% |
Q4 2021 | $2,848,000 | +10.0% | 70,764 | +2.2% | 0.00% | 0.0% |
Q3 2021 | $2,590,000 | +124.2% | 69,274 | +153.4% | 0.00% | +200.0% |
Q2 2021 | $1,155,000 | +34.5% | 27,333 | +51.6% | 0.00% | 0.0% |
Q1 2021 | $859,000 | +97.5% | 18,033 | +155.1% | 0.00% | 0.0% |
Q4 2020 | $435,000 | -62.5% | 7,070 | -71.1% | 0.00% | -50.0% |
Q3 2020 | $1,161,000 | +425.3% | 24,426 | +388.6% | 0.00% | +100.0% |
Q1 2020 | $221,000 | -4.7% | 4,999 | +3.4% | 0.00% | – |
Q4 2019 | $232,000 | -46.8% | 4,833 | -62.6% | 0.00% | -100.0% |
Q2 2018 | $436,000 | – | 12,921 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $294,255,421 | 5.60% |
Camber Capital Management LP | 2,500,000 | $101,675 | 3.31% |
COWEN AND COMPANY, LLC | 799,511 | $32,516,112 | 2.70% |
ARMISTICE CAPITAL, LLC | 3,236,000 | $131,608,120 | 1.90% |
SECTORAL ASSET MANAGEMENT INC | 231,696 | $9,423,076 | 1.57% |
GEORGE KAISER FAMILY FOUNDATION | 53,572 | $7,623,296 | 1.29% |
Redwood Investments, LLC | 245,578 | $9,987,657 | 1.22% |
Integral Health Asset Management, LLC | 174,000 | $7,076,580 | 0.88% |
Sofinnova Investments, Inc. | 260,443 | $10,592,217 | 0.69% |
SPHERA FUNDS MANAGEMENT LTD. | 100,100 | $4,071,067 | 0.64% |